CERS — Cerus Income Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMid CapNeutral
- $438.74m
- $417.82m
- $188.32m
- 55
- 25
- 38
- 32
Annual income statement for Cerus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 76.1 | 93.8 | 114 | 160 | 188 |
| Cost of Revenue | |||||
| Gross Profit | 44.4 | 60.4 | 73.1 | 96 | 113 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 131 | 160 | 173 | 208 | 222 |
| Operating Profit | -55 | -66.2 | -58.3 | -48.9 | -34.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -57.3 | -71 | -59.6 | -54.1 | -42.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -57.6 | -71.2 | -59.9 | -54.4 | -42.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -57.6 | -71.2 | -59.9 | -54.4 | -42.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -57.6 | -71.2 | -59.9 | -54.4 | -42.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.437 | -0.509 | -0.365 | -0.316 | -0.241 |